A detailed history of Avion Wealth transactions in Novavax Inc stock. As of the latest transaction made, Avion Wealth holds 325 shares of NVAX stock, worth $2,983. This represents 0.0% of its overall portfolio holdings.

Number of Shares
325
Previous 325 -0.0%
Holding current value
$2,983
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$6.81 - $9.74 $2,213 - $3,165
325 New
325 $2,000
Q1 2023

May 05, 2023

BUY
$5.76 - $12.48 $201 - $436
35 New
35 $0

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $718M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Avion Wealth Portfolio

Follow Avion Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.